Literature DB >> 8397288

Localization of the RNA-binding domain of mouse hepatitis virus nucleocapsid protein.

G W Nelson1, S A Stohlman.   

Abstract

The 454-amino acid nucleocapsid (N) protein of mouse hepatitis virus (MHV) binds the leader RNA sequence located at the 5' ends of all plus-sense genomic and subgenomic viral mRNAs. Purified N protein was cleaved with formic acid to determine which domain interacts with the leader RNA sequence. Incubation at 42 degrees C resulted in partial cleavage into two fragments of M(r)s of approximately 32K and 37K and three fragments of 17K, 16K and 14K. Incubation at 56 degrees C resulted in complete cleavage yielding only the three lower molecular mass products. Both the 32K and 37K partial cleavage products and one of the complete cleavage products bind MHV leader RNA, suggesting that the central region of the N protein contains the RNA-binding domain. Monoclonal antibody mapping of the cleavage products confirmed that the MHV leader RNA binding domain is contained within the central 140-amino acid fragment, comprising amino acids 169 to 308. Analysis of the amino acids within this domain indicates no similarity to any previously described RNA-binding protein, suggesting that N protein may possess a unique RNA-binding motif.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397288     DOI: 10.1099/0022-1317-74-9-1975

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  34 in total

1.  The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus.

Authors:  J A Hiscox; T Wurm; L Wilson; P Britton; D Cavanagh; G Brooks
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

3.  Mass spectroscopic characterization of the coronavirus infectious bronchitis virus nucleoprotein and elucidation of the role of phosphorylation in RNA binding by using surface plasmon resonance.

Authors:  Hongying Chen; Andrew Gill; Brian K Dove; Stevan R Emmett; C Fred Kemp; Mark A Ritchie; Michael Dee; Julian A Hiscox
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  A subgenomic mRNA transcript of the coronavirus mouse hepatitis virus strain A59 defective interfering (DI) RNA is packaged when it contains the DI packaging signal.

Authors:  E C Bos; J C Dobbe; W Luytjes; W J Spaan
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  The RNA binding domain of the hantaan virus N protein maps to a central, conserved region.

Authors:  Xiaolin Xu; William Severson; Noah Villegas; Connie S Schmaljohn; Colleen B Jonsson
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Analysis of second-site revertants of a murine coronavirus nucleocapsid protein deletion mutant and construction of nucleocapsid protein mutants by targeted RNA recombination.

Authors:  D Peng; C A Koetzner; P S Masters
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

7.  The murine coronavirus nucleocapsid gene is a determinant of virulence.

Authors:  Timothy J Cowley; Simon Y Long; Susan R Weiss
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

8.  Bovine coronavirus nonstructural protein 1 (p28) is an RNA binding protein that binds terminal genomic cis-replication elements.

Authors:  Kortney M Gustin; Bo-Jhih Guan; Agnieszka Dziduszko; David A Brian
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

9.  Replication and packaging of transmissible gastroenteritis coronavirus-derived synthetic minigenomes.

Authors:  A Izeta; C Smerdou; S Alonso; Z Penzes; A Mendez; J Plana-Durán; L Enjuanes
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Elucidation of the stability and functional regions of the human coronavirus OC43 nucleocapsid protein.

Authors:  Chun-Yu Huang; Yen-Lan Hsu; Wan-Ling Chiang; Ming-Hon Hou
Journal:  Protein Sci       Date:  2009-11       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.